428 related articles for article (PubMed ID: 31462412)
1. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Treatments for
Lamendella R; Wright JR; Hackman J; McLimans C; Toole DR; Bernard Rubio W; Drucker R; Wong HT; Sabey K; Hegarty JP; Stewart DB
mSphere; 2018; 3(1):. PubMed ID: 29359185
[No Abstract] [Full Text] [Related]
3. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
4.
Jenior ML; Leslie JL; Young VB; Schloss PD
mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
[TBL] [Abstract][Full Text] [Related]
5. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome and mycobiome in inflammatory bowel disease patients with
Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
[TBL] [Abstract][Full Text] [Related]
7. The role of fungi in C. difficile infection: An underappreciated transkingdom interaction.
Stewart D; Romo JA; Lamendella R; Kumamoto CA
Fungal Genet Biol; 2019 Aug; 129():1-6. PubMed ID: 30978391
[TBL] [Abstract][Full Text] [Related]
8. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
9.
Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
[TBL] [Abstract][Full Text] [Related]
10. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.
Han SH; Yi J; Kim JH; Lee S; Moon HW
PLoS One; 2019; 14(2):e0212626. PubMed ID: 30785932
[TBL] [Abstract][Full Text] [Related]
11. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.
Antharam VC; Li EC; Ishmael A; Sharma A; Mai V; Rand KH; Wang GP
J Clin Microbiol; 2013 Sep; 51(9):2884-92. PubMed ID: 23804381
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.
Robinson JI; Weir WH; Crowley JR; Hink T; Reske KA; Kwon JH; Burnham CD; Dubberke ER; Mucha PJ; Henderson JP
J Clin Invest; 2019 Aug; 129(9):3792-3806. PubMed ID: 31403473
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics investigation of
Fishbein SR; Robinson JI; Hink T; Reske KA; Newcomer EP; Burnham CD; Henderson JP; Dubberke ER; Dantas G
Elife; 2022 Jan; 11():. PubMed ID: 35083969
[No Abstract] [Full Text] [Related]
15. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection.
Vakili B; Fateh A; Asadzadeh Aghdaei H; Sotoodehnejadnematalahi F; Siadat SD
Curr Microbiol; 2020 Aug; 77(8):1673-1680. PubMed ID: 32296918
[TBL] [Abstract][Full Text] [Related]
18. Metagenome-assembled genomes (MAGs) suggest an acetate-driven protective role in gut microbiota disrupted by Clostridioides difficile.
Herrera G; Castañeda S; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
Microbiol Res; 2024 Aug; 285():127739. PubMed ID: 38763016
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
[TBL] [Abstract][Full Text] [Related]
20. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
